U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Show Filters
Hide Filters
Development Status
US Approved Rx
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Primary Target
Alpha-2A adrenergic receptor
1
Alpha-2B adrenergic receptor
1
Alpha-2C adrenergic receptor
1
Estrogen receptor alpha
1
Mineralocorticoid receptor
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Highest Phase
Approved
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Approval Year
1934
1
1996
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Condition
Abnormal uterine bleeding
1
Amenorrhea
1
Ocular hypertension
1
Open-angle glaucoma
1
Persistent (nontransient) facial erythema of rosacea
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Treatment Modality
Primary
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
CNS Activity
CNS Penetrant
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Originator
Corner, G.W.|Allen, W.M.
1
Pfizer
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Class
Chemical
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Code System
CHEBI
2
ChEMBL
2
DAILYMED
2
DRUG BANK
2
DRUG CENTRAL
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 1
DERMATOLOGICALS
1
GENITO URINARY SYSTEM AND SEX HORMONES
1
SENSORY ORGANS
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 2
OPHTHALMOLOGICALS
1
OTHER DERMATOLOGICAL PREPARATIONS
1
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 3
ANTIGLAUCOMA PREPARATIONS AND MIOTICS
1
OTHER DERMATOLOGICAL PREPARATIONS
1
PROGESTOGENS
1
PROGESTOGENS AND ESTROGENS IN COMBINATION
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 4
Other dermatologicals
1
Pregnen (4) derivatives
1
Progestogens and estrogens, fixed combinations
1
Sympathomimetics in glaucoma therapy
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Form
Principal Form
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Search results for
"ORPHAN DRUG|Designated|Treatment of ocular graft versus host disease"
in
comments
(approximate match)
Showing
1 - 2
of
2
results
Search within data set
First page disabled
Previous page disabled
1
Next page disabled
Next page disabled
Sort By
Approval Year, Recent
Approval Year, Oldest
Relevance
Display Name, A-Z
Display Name, Z-A
Least References
Most References
Oldest Change
Newest Change
BRIMONIDINE
MORE DETAILS
E6GNX3HHTE
Export Data
Search for Structure
Status:
Other
Class (Stereo):
CHEMICAL (ACHIRAL)
Progesterone
MORE DETAILS
4G7DS2Q64Y
Export Data
Search for Structure
Status:
Other
Class (Stereo):
CHEMICAL (ABSOLUTE)